Clinical Trial Update: Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies [Phase 3]

View source ↗

Summary

Phase 3 trial updating results for tislelizumab, pamiparib, and other investigational agents in participants with advanced malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignancies

Drugs mentioned

• Pamiparib (pamiparib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeOne Medicines | Conditions: Advanced Malignancies | Phase 3 | Status: COMPLETED